Butterfly Network, Inc. (NYSE:BFLY) is one of the top 10 healthcare AI stocks to buy according to hedge funds.
Craig-Hallum analyst Chase Knickerbocker has initiated coverage of Butterfly Network, Inc. with a Buy rating and a $3 price target, citing the company’s disruptive position in the point-of-care ultrasound market. Butterfly’s proprietary technology replaces traditional piezoelectric crystal-based ultrasound components with a chip-based semiconductor platform, allowing for a single probe to handle multiple imaging needs. This innovation not only reduces manufacturing complexity and cost, but also enables rapid software-driven improvements that set Butterfly apart from most handheld competitors.
A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the device.
The firm’s outlook is underpinned by Butterfly’s expanding direct-to-consumer (DTC) reach and a growing number of institutional partnerships, including leading health systems and academic centers. These relationships are expected to drive consistent hardware sales while building recurring revenue from software subscriptions.
Butterfly Network’s technology also places it at the forefront of healthcare’s digital transformation. By combining advanced imaging with real-time data interpretation and cloud-based collaboration tools, the company is integrating AI into clinical workflows to enhance diagnostic speed and accuracy.
READ NEXT: 13 Best Biotech Stocks To Invest In Now and 12 Best Healthcare Stocks to Buy Now.
Hedge Fund Resource Center